Rigel Pharmaceuticals Inc (RIGL)

NASDAQ · Biotechnology

45.91
+2.29 (+5.25%)
Updated Aug 19, 5:42 PM ET
AI Rating
Buy
Overall Score
69
Trend
75
Momentum
84
Risk
38

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 122 sessions Aug 18, 2026

AI Analysis

Rigel Pharmaceuticals Inc is trading at $45.91, up 5.25% on the session. The 50 day average sits at $38.33 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 65.4, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $36.14 with resistance near $43.99, so that band frames the current range. Average daily movement is roughly $1.96, or about 4.3% of the share price, which is what any stop placement has to allow for. The overall health score of 69 out of 100 combines a trend score of 75, momentum of 84 and a risk score of 38.

Technical indicators

RSI (14)
65.4
strong
MACD
1.240
bullish crossover
SMA 20
39.61
SMA 50
38.33
SMA 200
--
unknown
ATR (14)
1.96
avg daily range
Support
36.14
Resistance
43.99
Volume vs 20d
0.75x
below average
Volatility
43.9%
annualised
1 month
+9.96%
3 months
+52.46%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.